Is Abemaciclib the Go-to Drug for metastatic Breast Cancer?

Ramiven� Different by Design: New Delhi Chapter Dear Renukaprasad A R, Why is abemaciclib prominently used for treating HR+/HER2- MBC women with poor prognoses and liver metastasis? Attend this exclusive webinar on 19th September 2022 at 07:30 PM IST with our renowned experts in oncology, Dr. Anwar Al Nouri (Kuwait), Dr. Shyam Aggarwal, Dr. J. B. Sharma, Dr. Sushant Mittal, Dr. Samit Purohit, and Dr. Priya Tiwari, as they discuss what influences them in choosing abemaciclib for metastatic breast cancer (MBC) patients with poor prognosis and liver metastasis. In this Q&A-based session, the experts will address your questions live. We look forward to your participation in this informative discussion. Save Your Seat Ramiven� Different by Design: Kolkata Chapter Eli Lilly and Docplexus are hosting a webinar on September 20, 2022, at 7:30 PM IST. In this engaging session, Dr. Anwar Al Nouri (Kuwait), Dr. T.P. Sahoo, Dr. Chandrakanth M. V., Dr. P.N. Mohapatra, Dr. Bharat A. Vaswani, and Dr. Madhuchanda Kar will discuss their real-life experience based on the outcomes of CDK 4/6 inhibitors among metastatic breast cancer (MBC) patients. This webinar will also be followed by a live Q&A session. Session highlights: Clinical case presentation I - Dr. Anwar Al Nouri (Kuwait) Clinical case presentation II - Dr. Chandrakanth M. V. Clinical case presentation III - Dr. Bharat A. Vaswani Clinical case presentation IV - Dr. P.N. Mohapatra Q&A with the experts: Treatment alterations for patients with advanced MBC and poor prognostic indicators Click to Know More     A-302, Teerth Technospace, Mumbai-Bengaluru Highway, Baner, Pune-411045, India. +91-9850036954 Unsubscribe | Manage Preferences